Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia

Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia

US Patent 11471448 · Granted Oct 18, 2022

Estimated economic value: $799,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Serine protease inhibitor for treating coronavirus infection2025
Serine protease inhibitor for treating coronavirus infection2025
Therapy for inhibition of single-stranded RNA virus replication2025
Therapy for inhibition of single-stranded RNA virus replication2025
Biomarkers of coronavirus pneumonia2024
Biomarkers of coronavirus pneumonia2024
Biomarkers of coronavirus pneumonia2024
Biomarkers of coronavirus pneumonia2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
Serine protease inhibitor for treating coronavirus infection2024
Serine protease inhibitor for treating coronavirus infection2024
Method for eradicating Helicobacter pylori infection in patients regardless of b2024